Numeric Investors’s Adamas Pharmaceuticals ADMS Stock Holding History

Numeric Investors’s Portfolio ADMS Stock Details ADMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-14,300	Closed	-$375K	–	1208
2015 Q2	$375K	Sell	14,300 -46,724	-77%	-$909K	﹤0.01%	723
2015 Q1	$1.07M	Buy	61,024 +10,800	+22%	+$185K	0.01%	465
2014 Q4	$872K	Buy	+50,224	New	+$762K	0.01%	477

Other funds holding ADMS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CPH

C Partners Holding Zurich, Switzerland $317M AUM 4.76% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

OTPPB

Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $3.46B AUM 7.79% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

WSA

Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Numeric Investors's ADMS Position: Q3 2015 in Review

Numeric Investors sold out of Adamas Pharmaceuticals (ADMS) in Q3 2015, closing a stake of 14,300 shares — an estimated $375K sold.

Numeric Investors first reported a position in ADMS in Q4 2014 and held it in 3 quarters. The position peaked at $1.07M in Q1 2015. 83 funds tracked by Wall St. Rank hold ADMS as of Q3 2015.

Numeric Investors reported no remaining Adamas Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
Numeric Investors sold 14,300 Adamas Pharmaceuticals shares in Q3 2015, an estimated $375K.
Numeric Investors first reported a position in Adamas Pharmaceuticals in Q4 2014 and held it in 3 quarters.
Numeric Investors's Adamas Pharmaceuticals position peaked at $1.07M in Q1 2015.
83 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q3 2015.

Based on Numeric Investors's 13F filing for Q3 2015, filed 12 Nov 2015.